A 16S rRNA amplicon sequencing study in Morocco showed that both the gut microbiota and pathways of bacterial motility proteins and fatty acid metabolism were altered in CRC patients compared with healthy individuals (34). The gene discussed is PROS1; the disease is colorectal carcinoma.